Business Description
Abbott Laboratories (Pakistan) Ltd
ISIN : PK0025701019
Total Employee Number:
1,380Compare
Compare
Traded in other countries / regions
ABOT.Pakistan IPO Date
1982-06-14Description
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 26.18 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 162.27 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 7.04 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.2 | |||||
3-Year EBITDA Growth Rate | 26.5 | |||||
3-Year EPS without NRI Growth Rate | 35.8 | |||||
3-Year FCF Growth Rate | 227.3 | |||||
3-Year Book Growth Rate | 22.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 19.74 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.03 | |||||
9-Day RSI | 30.04 | |||||
14-Day RSI | 39.92 | |||||
3-1 Month Momentum % | -7.72 | |||||
6-1 Month Momentum % | -25.94 | |||||
12-1 Month Momentum % | -18.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.33 | |||||
Quick Ratio | 1.26 | |||||
Cash Ratio | 0.84 | |||||
Days Inventory | 103.16 | |||||
Days Sales Outstanding | 15.13 | |||||
Days Payable | 43.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.21 | |||||
Dividend Payout Ratio | 0.12 | |||||
3-Year Dividend Growth Rate | -34.1 | |||||
Forward Dividend Yield % | 4.21 | |||||
5-Year Yield-on-Cost % | 4.21 | |||||
Shareholder Yield % | 3.72 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.05 | |||||
Operating Margin % | 17.28 | |||||
Net Margin % | 10.97 | |||||
EBITDA Margin % | 21.19 | |||||
FCF Margin % | 8.25 | |||||
OCF Margin % | 12.36 | |||||
ROE % | 28.74 | |||||
ROA % | 18.62 | |||||
ROIC % | 27.24 | |||||
3-Year ROIIC % | 41.03 | |||||
ROC (Joel Greenblatt) % | 73.17 | |||||
ROCE % | 45.49 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10.92 | |||||
Forward PE Ratio | 12.18 | |||||
PE Ratio without NRI | 11.21 | |||||
Shiller PE Ratio | 19.8 | |||||
Price-to-Owner-Earnings | 15.43 | |||||
PEG Ratio | 1.1 | |||||
PS Ratio | 1.2 | |||||
PB Ratio | 2.69 | |||||
Price-to-Tangible-Book | 2.69 | |||||
Price-to-Free-Cash-Flow | 14.52 | |||||
Price-to-Operating-Cash-Flow | 9.69 | |||||
EV-to-EBIT | 5.58 | |||||
EV-to-EBITDA | 4.91 | |||||
EV-to-Revenue | 1.04 | |||||
EV-to-FCF | 13.18 | |||||
Price-to-GF-Value | 0.92 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Median-PS-Value | 0.74 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.06 | |||||
Price-to-Graham-Number | 1.16 | |||||
| Price-to-Net-Current-Asset-Value | 5.07 | |||||
Earnings Yield (Greenblatt) % | 17.93 | |||||
FCF Yield % | 6.88 | |||||
Forward Rate of Return (Yacktman) % | 12.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abbott Laboratories (Pakistan) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₨) | 75,756.003 | ||
| EPS (TTM) (₨) | 84.85 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.95 | ||
| 3-Year Sortino Ratio | 1.72 | ||
| Volatility % | 32.02 | ||
| 14-Day RSI | 39.92 | ||
| 14-Day ATR (₨) | 22.687981 | ||
| 20-Day SMA (₨) | 973.323 | ||
| 12-1 Month Momentum % | -18.45 | ||
| 52-Week Range (₨) | 821 - 1304 | ||
| Shares Outstanding (Mil) | 97.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abbott Laboratories (Pakistan) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abbott Laboratories (Pakistan) Ltd Stock Events
| Event | Date | Price (₨) | ||
|---|---|---|---|---|
| PKR 40.000000 Cash Dividend | 2026-04-22 | 996.25 (-0.37%) | ||
| PKR 10.000000 Cash Dividend | 2025-04-14 | 1,085.37 (+1.44%) |
Show
Entries
Abbott Laboratories (Pakistan) Ltd Frequently Asked Questions
What is Abbott Laboratories (Pakistan) Ltd(KAR:ABOT)'s stock price today?
The current price of KAR:ABOT is ₨926.63. The 52 week high of KAR:ABOT is ₨1304.00 and 52 week low is ₨821.00.
When is next earnings date of Abbott Laboratories (Pakistan) Ltd(KAR:ABOT)?
The next earnings date of Abbott Laboratories (Pakistan) Ltd(KAR:ABOT) is .
Does Abbott Laboratories (Pakistan) Ltd(KAR:ABOT) pay dividends? If so, how much?
The Dividend Yield %  of Abbott Laboratories (Pakistan) Ltd(KAR:ABOT) is 4.21% (As of Today), Highest Dividend Payout Ratio of Abbott Laboratories (Pakistan) Ltd(KAR:ABOT) was 1.45. The lowest was 0.12. And the median was 0.74. The  Forward Dividend Yield % of Abbott Laboratories (Pakistan) Ltd(KAR:ABOT) is 4.21%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Abbott Laboratories (Pakistan) Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers